HIF1A and arthritic joint disease: The chemotherapeutic agent Taxol, known to inhibit HIF‐1α production, has been demonstrated to mitigate collagen‐induced arthritis through modulation of the HIF‐1α/VEGF/ANG‐1 axis [86].